Patent details

EP1743655 Title: COMBINATIONS COMPRISING DIPEPTIDYLPEPTIDASE-IV INHIBITORS AND ANTIDIABETIC AGENTS

Basic Information

Publication number:
EP1743655
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP061218988
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATIONS COMPRISING DIPEPTIDYLPEPTIDASE-IV INHIBITORS AND ANTIDIABETIC AGENTS
French Title of Invention:
Combinaisons à base d'inhibiteurs de DPP-IV et d'antidiabetiques
German Title of Invention:
ZUSAMMENSETZUNGEN BESTEHEND AUS DIPEPTIDYLPEPTIDASE-IV INHIBITOREN UND ANTIDIABETICA
SPC Number:

Dates

Filing date:
19/01/2001
Grant date:
25/06/2014
EP Publication Date:
25/06/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/01/2007
EP B1 Publication Date:
25/06/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/01/2019
Expiration date:
19/01/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/01/2001
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
Villhauer Edwin Bernard
Address:
United States (US)

2

Name:
Holmes David Grenville
Address:
Switzerland (CH)

3

Name:
Hughes Thomas Edward
Address:
United States (US)

4

Name:
Balkan Börk
Address:
United States (US)

Priority

1

Priority Number:
489234
Priority Date:
21/01/2000
Priority Country:
United States (US)

2

Priority Number:
619262
Priority Date:
19/07/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 45/06;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
08/01/2018
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
31/05/2019 Outgoing Correspondence 1